RT Book, Section
A1 Boyd, Leslie
A1 Muggia, Franco
A2 Boyiadzis, Michael M.
A2 Frame, James N.
A2 Kohler, David R.
A2 Fojo, Tito
SR Print(0)
ID 1159262643
T1 Vaginal Cancer
T2 Hematology-Oncology Therapy, 2e
YR 2016
FD 2016
PB McGraw-Hill Education
PP New York, NY
SN 9780071637893
LK hemonc.mhmedical.com/content.aspx?aid=1159262643
RD 2024/04/23
AB EpidemiologyTable  Graphic  Jump  Location|Download  (.pdf)|PrintEpidemiologyIncidence:3,170  (Estimated  new  cases  for  2014  in  the  United  States)Incidence  of  clear  cell  adenocarcinoma  as  a  result  of  in  utero  diethylstilbestrol(DES)  exposure  estimated  at  1/1000Stage  at  presentationStage  I:28%Stage  II:43%Deaths:Estimated  880  in  2014Stage  III:16%Median  age:Squamous  cell  cancer  (60–65  years);  DES-related  adenocarcinoma/clear  cell  (19  years)Stage  IV:13%  Daling  JR  et  al.  Gynecol  Oncol  2002;84:263–270Siegel  R  et  al.  CA  Cancer  J  Clin  2014;64:9–29Tedeschi  C  et  al.  J  Low  Genit  Tract  Dis  2005;9:11–18